Invention Grant
- Patent Title: GSK-3 inhibitors
-
Application No.: US16463451Application Date: 2017-11-27
-
Publication No.: US10774086B2Publication Date: 2020-09-15
- Inventor: Richard A. Hartz , Vijay T. Ahuja , Prasanna Sivaprakasam , Gene M. Dubowchik , John E. Macor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2017/063230 WO 20171127
- International Announcement: WO2018/098411 WO 20180531
- Main IPC: A61K31/5025
- IPC: A61K31/5025 ; C07D487/04
Abstract:
The disclosure generally relates to compounds of formula (I), including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.
Public/Granted literature
- US20190276463A1 GSK-3 INHIBITORS Public/Granted day:2019-09-12
Information query
IPC分类:
